Wolverine Trading, LLC Pfizer Inc Put Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Put Options

27 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $4.45 Million - $5.04 Million	160,500 Added 14.63%	1,257,500 $36.4 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $5.89 Million - $6.9 Million	233,000 Added 26.97%	1,097,000 $30.7 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $2.46 Million - $2.83 Million	95,100 Added 12.37%	864,000 $24 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $6.68 Million - $8.67 Million	255,500 Added 49.77%	768,900 $22.1 Million
Q3 2023 Nov 15, 2023	BUY	$32.09 - $37.51 $176,495 - $206,305	5,500 Added 1.08%	513,400 $17 Million
Q2 2023 Aug 23, 2023	BUY	$36.12 - $41.79 $931,895 - $1.08 Million	25,800 Added 5.35%	507,900 $18.6 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $19 Million - $24.7 Million	482,100 New	482,100 $19.5 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $3.12 Million - $3.81 Million	-71,400 Reduced 12.32%	508,100 $22.4 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $5.1 Million - $6.04 Million	-109,500 Reduced 15.89%	579,500 $29.5 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $640,500 - $793,660	-14,000 Reduced 1.99%	689,000 $36.1 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $958,624 - $1.42 Million	23,200 Added 3.41%	703,000 $41.1 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $2.83 Million - $3.64 Million	-72,200 Reduced 9.6%	679,800 $29.6 Million
Q2 2021 Aug 06, 2021	BUY	$35.91 - $40.68 $8.29 Million - $9.39 Million	230,900 Added 44.31%	752,000 $29.4 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $7.08 Million - $7.98 Million	211,400 Added 68.26%	521,100 $18.8 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $5.24 Million - $6.66 Million	-156,600 Reduced 33.58%	309,700 $11.4 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $1.42 Million - $1.67 Million	44,800 Added 10.63%	466,300 $16.9 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $2.39 Million - $2.9 Million	79,500 Added 23.25%	421,500 $13.8 Million
Q1 2020 May 11, 2020	BUY	$27.03 - $38.62 $824,415 - $1.18 Million	30,500 Added 9.79%	342,000 $11.2 Million
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $1.47 Million - $1.67 Million	-44,600 Reduced 12.52%	311,500 $12.1 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $2.86 Million - $3.7 Million	87,900 Added 32.77%	356,100 $12.9 Million
Q2 2019 Aug 20, 2019	SELL	$36.98 - $41.52 $2.66 Million - $2.99 Million	-72,000 Reduced 21.16%	268,200 $11.6 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $1.49 Million - $1.63 Million	39,600 Added 13.17%	340,200 $14.4 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $738,624 - $842,112	19,200 Added 6.82%	300,600 $12.9 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $1.34 Million - $1.63 Million	-39,000 Reduced 12.17%	281,400 $12.4 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $465,886 - $540,492	-14,600 Reduced 4.36%	320,400 $11.4 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $4.97 Million - $5.27 Million	-149,300 Reduced 30.83%	335,000 $12.1 Million
Q3 2017 Nov 15, 2017	BUY	$31.0 - $34.15 $15 Million - $16.5 Million	484,300	484,300 $17.3 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.8 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.76 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.37 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.48 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account